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statistical models with continuous and
discontinuous risk intervals on recurrent malaria
episodes data
Issaka Sagara1,2*, Roch Giorgi2, Ogobara K Doumbo1, Renaud Piarroux3 and Jean Gaudart2Abstract
Background: Recurrent events data analysis is common in biomedicine. Literature review indicates that most
statistical models used for such data are often based on time to the first event or consider events within a subject
as independent. Even when taking into account the non-independence of recurrent events within subjects, data
analyses are mostly done with continuous risk interval models, which may not be appropriate for treatments
with sustained effects (e.g., drug treatments of malaria patients). Furthermore, results can be biased in cases of a
confounding factor implying different risk exposure, e.g. in malaria transmission: if subjects are located at zones
showing different environmental factors implying different risk exposures.
Methods: This work aimed to compare four different approaches by analysing recurrent malaria episodes from a
clinical trial assessing the effectiveness of three malaria treatments [artesunate + amodiaquine (AS + AQ), artesunate +
sulphadoxine-pyrimethamine (AS + SP) or artemether-lumefantrine (AL)], with continuous and discontinuous risk
intervals: Andersen-Gill counting process (AG-CP), Prentice-Williams-Peterson counting process (PWP-CP), a shared
gamma frailty model, and Generalized Estimating Equations model (GEE) using Poisson distribution. Simulations
were also made to analyse the impact of the addition of a confounding factor on malaria recurrent episodes.
Results: Using the discontinuous interval analysis, AG-CP and Shared gamma frailty models provided similar
estimations of treatment effect on malaria recurrent episodes when adjusted on age category. The patients
had significant decreased risk of recurrent malaria episodes when treated with AS + AQ or AS + SP arms compared
to AL arm; Relative Risks were: 0.75 (95% CI (Confidence Interval): 0.62-0.89), 0.74 (95% CI: 0.62-0.88) respectively for
AG-CP model and 0.76 (95% CI: 0.64-0.89), 0.74 (95% CI: 0.62-0.87) for the Shared gamma frailty model.
With both discontinuous and continuous risk intervals analysis, GEE Poisson distribution models failed to detect the
effect of AS + AQ arm compared to AL arm when adjusted for age category. The discontinuous risk interval analysis
was found to be the more appropriate approach.
Conclusion: Repeated event in infectious diseases such as malaria can be analysed with appropriate existing models
that account for the correlation between multiple events within subjects with common statistical software packages,
after properly setting up the data structures.
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Recurrent events data analysis is quite common in bio-
medicine, such as low back pain, sick leave from work,
sporting injuries, hospital readmissions and episodes of
infectious diseases such as malaria [1-7]. Literature review
indicates that most statistical models applied to such data
are often based on naive techniques. Such naive tech-
niques are characterized by either ignoring the existence
of recurrent events, or ignoring the fact that the recurrent
events within subjects are correlated [1,2]. Even when
taking into account the non-independence of recurrent
events within subjects, data analyses are mostly done with
continuous risk interval models [2-5], which may not be
relevant for health conditions with discontinuous risk [8].
In the medical field, it is quite common to encounter
recurrent health conditions with such discontinuous risk
intervals, e.g. in cases with persistent treatment effect.
Examples include infections, such as malaria, disability
episodes, hospitalizations, and nursing home admissions
[7-12]. When subjects have a disability episode, they are
not at risk of the second episode of disability until they
have recovered from the first episode. To obtain unbiased
estimates of incidence rates, the person-time period when
the subject is not at risk should be excluded from the risk
set. When analysing recurrent time-to-event outcomes
with discontinuous risk intervals the subject is not at risk
of another event while a previous one is ongoing or if the
subject is under treatment. Appropriate models for analys-
ing recurrent events data include marginal models or
frailty or random coefficient analysis models [8-13], which
take into account the non independence assumption of
events within the subject.
Furthermore, in the case of malaria treatment trials,
investigators assume that randomization is sufficient for
controlling differential risk. However, the location of
each subject is important as the risk exposure shows
high spatial variations due to different environmental
factors [14,15] that must be taken into account.
This work aimed at comparing different approaches
analysing recurrent malaria episodes, with continuous
and discontinuous risk interval models, in order to con-
tribute identifying useful models to analyse such malaria
data.
Methods
Study design
Data were collected from July 2005 to July 2007 in
Bougoula-Hameau, Sikasso, in the south region of Mali.
Patients were randomized as they came to the health
centre from July 2005 to October 2006 (accrual period) to
one of the artemisinin-based combination therapy (ACT)
arm: artesunate + amodiaquine (AS + AQ) or artesunate +
sulphadoxine-pyrimethamine (AS + SP) or artemether-
lumefantrine (AL). The study’s main objective was tocompare malaria incidence between these three ACT. Pa-
tients received the same initial treatment at each subse-
quent episode of uncomplicated malaria during the course
of the study. The clinical data and results related to the
main objective were published elsewhere [7].
Statistical models and data analysis
Four models were used for the analysis of recurrent time-
to-event outcomes: i) Generalized estimating equations
(GEE) model using a Poisson distribution; and three ex-
tended Cox models: ii) the Andersen-Gill counting process
(AG-CP), iii) the Prentice-Williams-Peterson counting
process (PWP-CP); and iv) the Shared gamma frailty model.
To take into account the recurrent structure of the data,
models i) to iii) are marginal and model iv) uses a shared
frailty term.
Both continuous and discontinuous time interval ap-
proaches were used with the four different models to
analyse the data. A 14 day washout period was estimated
after each episode treatment based on the pharmacokin-
etics of the study drugs. Model results were evaluated by
comparing the risk ratio (RR) estimates and their stand-
ard errors (SE).
To analyse the impact of a confounding factor on re-
sults, a simulation of a risk exposure was done with two
levels (high risk exposure versus low risk exposure) using a
Binomial distribution with parameter (probability of being
in the high risk exposure class) depending on the number
of malaria episodes: 0.99 if the subject experienced >6 mal-
aria episodes else 0.75 if the subject experienced > 4 mal-
aria episodes, else 0.25 if subject experienced >1 episode
and otherwise 0.01. This binary factor simulates, for
example, two zones of different exposure. For analys-
ing the impact of such a confounding factor, 1,000 in-
dependent replicates were performed, using R2.15.2
software (The R Foundation for Statistical Computing,
Vienna, Austria). With the simulation data, only dis-
continuous time interval analysis was done with each
of the four models. The impact of the simulated con-
founding factor on the results for each model was
assessed by comparing the magnitude and confidence
intervals of RR estimates, power and empirical cover-
age rates (ECR). For each covariate, the ratio between
the standard error (SE) of the estimates using simulated
data and the SE of the estimates using the observed data
was computed. These criteria can be interpreted as the
impact of the confounding factor on the estimation
accuracy.
GEE model using Poisson distribution
The Poisson regression model is frequently used to ana-
lyse count data or to study disease incidence and mortal-
ity when the dependent variable represents the number
of independent events that occur during a fixed period
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events) can be written as:
Ln Y X; βÞ ¼ Xiβjð ð1Þ
Where, Xiβ = β0 + β1X1 + β2X2 +… + βnXn; Ln is the
natural logarithm (the canonical link between the linear
predictors and the conditional mean of Y).
The GEE Poisson estimates the same model as the
standard Poisson regression allowing for dependence
within clusters. Therefore, it is appropriate to model re-
current events within a subject, such as in longitudinal data.
The regression coefficients are refit, correcting iteratively
for the correlation. In such models, the within-subject cor-
relation structure is treated as a nuisance parameter. In this
work the exchangeable correlation structure has been used
assuming that the correlation between events remained
constant through the time [17].Extended Cox models
The extended Cox models are used to model recurrent
events within a subject unlike the Cox model, which is
used to model a unique event or, sometimes, the first
event. The considered Cox extended models were: the
counting process model (Anderson-Gill model or AG-CP)
[18], and the conditional model (Prentice-Williams-Peter-
son counting process model or PWP-CP) [16].
The sandwich robust standard error of Lin and Wei
[3,19], which is a variance-correction technique, is usu-
ally employed together with these Cox extended models
to avoid inflation of type I error due to multiple observa-
tions per individual which do not require specification of
the correlation matrix.The Anderson-Gill model (AG-CP)
The formula is written as:
λik t=X; βð Þ ¼ 〛ik tð Þλ0 tð ÞeXikβ ð2Þ
λik(t) represents the hazard function for the k
th event of
the ith subject at time t; λ0(t) represents the common
baseline hazard for all events over time; Xik represents
the vector of p covariates processes for the ith individual;
β is a fixed vector of p coefficients; 〛 ik is a predictable
process, taking values in {1,0} indicating when the ith in-
dividual is under observation.
The AG-CP model uses this counting process time-
scale for all episodes. The time-scale does not reset to 0
after an episode (Table 1). Data for each subject needs to
be entered in the counting process style, with a start time,
stop time and censoring indicator for each event.Conditional model (Prentice-Williams-Peterson counting
process-PWP-CP):
The PWP-CP model is similar to the AG-CP model but
stratified by events. The formula is written as:
λik t X; βÞ ¼ 〛ik tð Þλ0k tð ÞeXikβ
 ð3Þ
λ0k(t) represents the event-specific baseline hazard for the
kth event over time. In this model, a subject is assumed
not to be at risk for a subsequent event until a current
event has terminated.
The shared frailty model
The frailty model, introduced in the biostatistical litera-
ture by Vaupel et al. [20], and discussed in detail by
Hougaard, Duchateau and Janssen, and Wienke et al.
[21-23], accounts for the heterogeneity in baseline. This
model is an extension of the proportional hazards model
in which the hazard function depends upon an unob-
servable random variable. Subjects may be exposed to
different risk levels, even after controlling for known risk
factors, because of some relevant unobserved covariates.
The frailty parameter models these unknown covariates.
In a shared frailty model, individuals in the same group
share the same frailty value which generates dependence
between those individuals who share frailties.
The shared frailty model can be written as follows:
λik t=X; β; uð Þ ¼ uiλik tð Þ ¼ λ0 tð ÞeXikβþui ð4Þ
Where λik is the conditional hazard function for the
kth subject from the ith cluster (conditional on ui); λ0(t)
is the baseline hazard; β is the fixed effects vector of di-
mension p; Xik is the vector of covariates; ui is the random
effect for the ith cluster. Subjects in the same cluster u
share the same frailty factor [22]. It is a conditional hazard
model, given the ui. The cluster may represent a family,
for example, or as in this case a single subject for which
multiple episodes are observed.
The distribution of u may be Gamma, Gaussian, or
other distribution. The gamma distribution has been
chosen because of its mathematical tractability and be-
cause it is widely used [22]. The one-parameter chosen
gamma distribution is defined as:
f w uð Þ ¼
v1=θ−1e −u=θð Þ
θ
1
θΓ 1=θð Þ ð5Þ
with Γ the gamma function. Note that E(u) = 1 and
Var(u) = θ. This gives the following interpretation: subject
in a class i with ui > 1 are frail, meaning of higher risk
while subject with ui <1 are strong, meaning of lower risk.
The parameter θ informs on the clusters or classes hetero-
geneity in the population.
Table 1 Data structures for modelling recurrent time-to-event outcomes
ID Start End Episode Order Time Treatment Age (Years) Quarter
1 0 28 1 1 28 AS + SP 3.93 1
1 42 52 1 2 10 AS-SP 3.93 1
1 476 700 0 10 224 AS + SP 3.93 1
2 0 77 1 1 77 AS + AQ 1.15 1
2 91 375 1 2 284 AS + AQ 1.15 1
2 417 700 0 4 283 AS + AQ 1.15 1
3 0 28 1 1 28 AL 1.48 1
3 42 78 1 2 36 AL 1.48 1
3 150 700 0 5 550 AL 1.48 1
Data dictionary:
ID: study subject identification number; start: the start time of the interval (in days); end: the time (in days) at which the event occurs or the time of censoring;
episode, the occurrence of malaria episode (yes = 1, no = 0); order: the order of the episodes, which is used only for the PWP-CP model; time: the number of days
at risk that is calculated from subtracting end from start variables; treatment: the same malaria treatment given to the patient during each episode; Age (Years):
the patients age at enrolment in years; quarter: the resident place or bloc of the patient in the village (old quarter = 1, new quarter = 0).
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hazard function for the frailty model does not vary by
event, but the coefficient estimates of covariates effect
from the frailty model, unlike the Cox model may vary if
there is a significant random effect.
For the baseline hazard function, although other distri-
bution could be used, the Weibull proportional hazards
distribution was assumed. Weibull distributed event
times are often used in practice, because they are able to
describe the actual evolution of the hazard function in
an appropriate way in many circumstances. Furthermore
it is a popular flexible parametric model that allows the
inclusion of covariates of the survival times [22].
Data structure
The duration of each subject in the study was defined as
the time between enrolment and the end of the study or
until the subject is lost to follow or withdrawn. A mal-
aria episode (event) had to be preceded and followed by
a time period without malaria except in the case of with-
drawal and at the end of the study period. As an ex-
ample, Table 1 provides data for three study subjects
(one in each study arm). Subject 1 had nine malaria epi-
sodes at days 28, 52, 80, 109, 305, 326, 410, 438 and 462
and the follow-up ended on day 700. Subject 2 had three
malaria episodes at days 77, 375 and 403 and the follow-
up ended on day 700. Subject 3 had four malaria epi-
sodes at days 28, 78, 105 and 136 and the follow-up
ended on day 700. The duration of each malaria episode
is 14 days as it is assumed that the subject is not at risk
of new infection for this duration after treatment initi-
ation (discontinuous risk interval data structure).
The data are organized as one record per subject per
event. The data structure for the AG-CP model consists
of the first four columns. A subject with multiple events
is considered as multiple subjects for analytic purposes.For example, subject 2 is considered four times: the first
begins follow-up at time 0 and has an event at 77 days;
according to the fact that the subject is not at risk during
14 days, the second has delayed entry at 91 days and has
an event at 375 days; the third has delayed entry at
389 days and has an event at 403 and is followed through
700 days without having an event. Because the counting
process model does not consider the order of the events,
it does not use the “order” column. In the PWP-CP model,
a subject is assumed not to be at risk for a subsequent
event until the current event has terminated. This means,
one cannot be at risk for the second event without having
experienced and completed the first event. The data struc-
ture for PWP-CP model is similar to that of the counting
process AG-CP model except that the “order” column is
also used to identify the event order. An Additional file 1
shows statistical codes for each model using Stata and R
Software [see Additional file 1].
Incidence rate and relative risk estimate of recurrent
events
The incidence rate was computed as the number of
events per person-days [24] and can be calculated from
Table 1 as follows:
Xn
k¼1
eventij
Xn
k¼1
timeij
where eventij is the event status (1 or 0) for the i
th subject
in the jth interval; timeij is the time at risk for the i
th sub-
ject in the jth interval; n is the number of subjects. The
relative risks (RRs) were computed to assess the treatment
effect (AL study arm was used as the reference treatment)
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old and >9 years old. The age group >9 years old was used
as reference group) on the occurrence of malaria episode.
The hazard ratio (HR) for extended Cox models and the
relative risk (RR) for the GEE model were estimated.Ethical considerations
The study has been approved from the institutional ethical
committee (FWA #00001769) at the Faculty of Medicine,
Pharmacy and Odonto-Stomatogy (FMPOS)/USTTB,
Bamako, Mali.
A written consent was also obtained from each partici-
pant or their parent/legal guardian.Results
From July 2005 to July 2007, the 777 subjects enrolled
into the study yielded a total of 1,649 malaria episodes
(min = 1, max = 12, median = 2 episodes per subject).
Using the discontinuous risk interval analysis, PWP-CP,
AG-CP, and the Shared gamma frailty models provided
larger treatment effect on malaria episodes compared to
GEE for the patients treated with AS + AQ or AS + SP
as compared to the AL arm; RRs were: 0.75 (95% CI
(Confidence Interval): 0.62-0.89), 0.74 (95% CI: 0.62-
0.88) respectively for AG-CP model, 0.76 (95% CI: 0.64-
0.89), 0.74 (95% CI: 0.62-0.87) for the Shared gamma
frailty model and 1.02 (0.93-1.11), 0.93 (0.87-0.99) for
GEE model (Table 2). Similarly for the age category, using
the discontinuous (Table 2) risk interval analysis, PWP-
CP, AG-CP and the Shared gamma frailty models provided
similar and higher magnitude of RRs for the patients in
age group <5 years old or age group between 5-9 years old
compared to patients of age group >9 years old; RRs were:
3.16 (95% CI: 2.15-4.65), 2.61 (95% CI: 1.76-3.88) respect-
ively for AG-CP model and 3.04 (95% CI: 2.27-4.09), 2.54
(95% CI: 1.87-3.45) respectively for Shared gamma frailty
model. The effect of covariates (treatments and age
category) on malaria episodes were slightly higher for
both AG-CP and the Shared gamma frailty models inTable 2 Coefficient estimates according to model by discontin
Models AS + AQ* RR/HR (SE);
[95% CI]; p
AS + SP* RR/H
[95% CI]; p
GEE, Poisson distribution 1.02 (0.044); [0.93-1.11];
p = 0.722
0.93 (0.029); [0
p = 0.018
AG-CP 0.75 (0.068); [0.62-0.89];
p < 0.001
0.74 (0.065); [0
p < 0.001
PWP-CP 0.86 (0.055); [0.76-0.97];
p = 0.015
0.85 (0.052); [0
p = 0.007
Shared gamma frailty 0.76 (0.064); [0.64-0.89];
p = 0.001
0.74 (0.063); [0
p < 0.001
*Reference treatment: AL.
**Reference age group: >9 years old.
CI: Confidence interval for RR/HR (Relative risk/Hazard ratio); SE: Standard error; p: pdiscontinuous risk intervals (Table 2) compared to
continuous risk intervals (Table 3).
Using both discontinuous (Table 2) and continuous
(Table 3) risk intervals analysis, GEE Poisson models did
not find a preventive efficacy for the patients treated
with AS + AQ arm compared to AL arm. Furthermore,
the GEE models estimated a protective efficacy (1-RR) of
lower magnitude for AS + SP than the 3 other models.
The discontinuous (Table 2) and continuous (Table 3)
risk intervals analysis results were similar for GEE
Poisson model.
Incidence rates (Table 4) were slightly higher in the
discontinuous interval analysis compared to the continu-
ous interval analysis as the person-time was lower, al-
though the 5% significance level was not reached for the
incidence rate differences between treatment groups
(exact mid p-values).
Assessing the impact of risk exposure covariate with
the simulated data (Figure 1), treatment effect estimates
(AS + AQ and AS + SP compared to AL) were relatively
lower than those with observed data for the AG-CP and
the Shared gamma frailty models, but still remain signifi-
cant for each extended Cox models. For the GEE model,
there were no significant treatment at 5% for both AS +AQ
and AS + SP compared to AL. Simulated data (Figure 1)
confirmed the significant (at 5% significant level) treat-
ment effect of AS +AQ and AS + SP compared to AL with
power > 80% for all models except the GEE Poisson dis-
tribution model. Also, the age category effects (age cat-
egory < 5 years and age category 5-9 years old compared
to the age category > 9 years old) on malaria episodes were
relatively lower compared to the effects of the age category
on malaria episodes using the observed data analysis. For
the GEE model, there were moderate to no significant age
category effects.
The simulated data (Figure 1) showed that adding a
significant covariate reduces estimation variances. For
the AS + AQ treatment, the standard error ratio (simu-
lated over observed) for the AG-CP model was 0.72
(2.5-97.5 percentile [0.60-0.85]), while it was 0.16 (2.5-uous risk intervals analysis
R (SE); <5 years** RR/HR (SE);
[95% CI]; p
5-9 years** RR/HR (SE);
[95% CI]; p
.87- 0.99]; 1.36 (0.201); [1.02-1.82];
p = 0.036
1.22 (0.181); [0.91-1.63];
p = 0.175
.62-0.88]; 3.16 (0.621); [2.15-4.65];
p < 0.001
2.61 (0.526); [1.76-3.88];
p < 0.001
.75-0.96]; 2.34 (0.389); [1.69-3.24];
p < 0.001
2.04 (0.345); [1.46-2.84];
p < 0.001
.62-0.87]; 3.04 (0.458); [2.27-4.09];
p < 0.001
2.54 (0.397); [1.87-3.45];
p < 0.001
value.
Table 3 Coefficient estimates according to model by continuous risk intervals analysis
Models AS + AQ* RR/HR (SE);
[95% CI]; p
AS + SP* RR/HR (SE);
[95% CI]; p
<5 years** RR/HR (SE);
[95% CI]; p
5-9 years** RR/HR (SE);
[95% CI]; p
GEE, Poisson distribution 1.02(0.044); [0.93-1.11];
p = 0.722
0.93 (0.029); [0.87- 0.99];
p = 0.02
1.36 (0.201); [1.02-1.82];
p = 0.04
1.22 (0.181); [0.91-1.63];
p = 0.18
AG-CP 0.77 (0.064); [0.65-0.91];
p = 0.002
0.76 (0.062); [0.65-0.89];
p = 0.001
2.94 (0.559); [2.03-4.27];
p < 0.001
2.48 (0.481); [1.69-3.62];
p < 0.001
PWP-CP 0.83 (0.053); [0.73-0.94];
p = 0.004
0.81 (0.050); [0.72-0.92];
p = 0.001
2.35 (0.388); [1.71-3.26];
p < 0.001
2.05 (0.344); [1.48-2.85];
p < 0.001
Shared gamma frailty 0.77 (0.061); [0.66-0.90];
p = 0.001
0.76 (0.060); [0.65-0.89];
p < 0.001
2.88 (0.415); [2.17-3.82];
p < 0.001
2.43 (0.364); [1.82-3.26];
p < 0.001
*Reference treatment: AL.
**Reference age group: >9 years old.
CI: Confidence interval for RR/HR (Relative risk/Hazard ratio); SE: Standard error; p: p value.
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model. For the AS + SP treatment, the standard error ra-
tio (simulated over observed) for the AG-CP model was
0.75 (2.5-97.5 percentile [0.63-0.89]), while it was 0.25
(2.5-97.5 percentile [0.23-0.54]) for GEE Poisson distribu-
tion model. The AS + SP effect estimates was clearly modi-
fied when using the GEE model (ECR = 7.7%), similarly to
small age categories effect estimates when using the Shared
gamma frailty model (ECR = 16.1%). AG-CP and PWP-CP
models estimates were particularly stable after the addition
of the simulated confounding covariate.
Discussion
Methods are available to analyse data with recurrent
events while accounting for the lack of independence
among events [3-6,8-13]. In this paper, when focusing
on recurrent malaria episodes data, results were different
according to the model used, highlighting the importance
of the model choice according to the medical question
studied and the collected dataset. Two other survival
models for recurrent events [3,8,20] have been proposed:
Wei-Lin-Weissfeld (WLW), Prentice-Williams-Peterson
gap time (PWP-GT). Various earlier studies have dis-
cussed the difficulty in conceptualizing the risk set of the
WLW model and the biases in the estimates from the
WLW and PWP-GT models [3,6,25], so these two models
were not considered here. There is a limited applied
statistical research modelling malaria recurrent episodes
data [12], though malaria is one of the most devastatingTable 4 Incidence rate* per treatment arm according to disco
Model AL
IR [95% CI]
Discontinuous time risk intervals 2.01 [1.86-2.17]
Continuous time risk intervals 1.87 [1.73-2.02]
p-value 0.09
*Malaria episodes/person/year.
IR: Incidence rate; CI: Confidence interval for IR; p-values: Exact mid p-values for riskdiseases in sub-Saharan Africa. The literature review indi-
cates that, this is the first applied statistical research mod-
elling using the main extended Cox models on recurrent
malaria episodes data with both discontinuous and con-
tinuous risk intervals. The data structures have been effi-
ciently prior organized with discontinuous risk intervals in
order to perform the analysis using these different models.
For these analyses, the time while the subject is not at risk
because of the malaria treatment has to be taken into ac-
count and excluded from the risk set. There is a need of
careful preparation of the data structure before applying
theses analyses.
The AG-CP and the Shared gamma frailty models,
with both discontinuous and continuous risk intervals
provided similar parameter estimates of treatment ef-
fects (with respect to the referent treatment) or for age
category effects (in respect to age referent category) on
malaria recurrent episodes. This was previously observed
by others [8] where the authors reported significant co-
variate effect estimates using AG-CP and the Shared
gamma frailty models with discontinuous risk intervals
analysis. AG-CP models are known to be useful and
robust if one is interested in the overall effect, such as
the treatment effect in a clinical trial, and if there is no
clear biological mechanism underlying the relation be-
tween the first event and subsequent events [8,11]. The
actual used data seems adapted to this described situation
where having the first malaria episode does not preclude
subsequent malaria episode as long as exposure is presentntinuous or continuous risk intervals analysis
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IR [95% CI] IR [95% CI]
1.52 [1.39-1.66] 1.50 [1.37-1.64]
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100%
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Power
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Figure 1 Coefficients estimate using observed and simulated data using discontinuous risk intervals analysis. Dark dots with lines are
Relative risk/Hazard ratio and their 95% Confidence intervals respectively; Vertical central dark line is either the no effect treatment line compared
to the referent category (artemether-lumefantrine) or the no effect age group compared the referent category (age group > 9 years old).
Abbreviations: AS + AQ, artesunate + amodiaquine; AS + SP, artesunate + sulphadoxine-pyrimethamine; AG, Andersen-Gill; PWP, Prentice-Williams-
Peterson; GEE, generalized estimating equation; SE, standard error; ECR, empirical coverage rate.
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counting process (or AG-CP) model requires few assump-
tions, and is comparably robust like the traditional Cox re-
gression model [3,18]. Although the Shared gamma frailty
models generated similar results to the AG-CP model in
this study, the specification of the frailty distribution may
affect the coefficient estimates and more research is still
needed in this area [8,22].
AS + SP, then followed by AS +AQ showed significant
protective effects (1-RR) against recurrent malaria episodes
compared to AL using the three extended Cox models
(AG-CP, PWP-CP and the Shared gamma frailty). This
could be explained by the longer half-life of the partner
drugs (AQ and SP) and this observation has been reportedpreviously [7]. In contrast, both the age category of <5 years
old and the age category of 5-9 years old were significantly
at higher risk of recurrent malaria episodes compared to
old children and adults (>9 years old) using the three
extended Cox models (AG-CP, PWP-CP and the Shared
gamma frailty).
Time discontinuous or continuous risk intervals models
should be chosen based on the disease or outcome condi-
tions. In this case, the discontinuous risk intervals model
should be chosen for unbiased estimates of covariate coef-
ficients as shown in these data and also reported previously
[8]. It is also more appropriate from an epidemiological
point of view to take into account the time a subject is not
at risk for a disease in a given period of time.
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referent category) were found on malaria recurrent epi-
sodes using GEE for both discontinuous and continuous
risk intervals models which yielded similar coefficient es-
timates. GEE is considered a very flexible approach [26].
Indeed, GEE models can handle a variety of correlated
measure models that arise from recurrent episodes
measure in the same individuals over time [27-29]. GEE
models are robust to misspecification of the correlations
structures [26]. Selecting robust standard errors (Huber/
White Sandwich Estimators; as opposed to conventional
standard errors) allow the estimates to be valid even if
the correlation structure is misspecified. The poor per-
formance of GEE, shown here, may also be explained by
inappropriate assumption of the Poisson distribution
[30] as the data maybe underdispersed with 70% of the
dependant value count greater than zero.
Analyses including the simulated variables also showed
significant treatments (AS + AQ and AS + SP using AL
as referent category) and age category (using >9 years
old as referent category) effects on malaria recurrent ep-
isodes with AG-CP, PWP-CP and the Shared gamma
frailty models as in observed data analysis though these
effects were more important for AG-CP and the Shared
gamma frailty models.
The simulation study showed that a risk exposure factor
modified the estimates, reducing the treatment effects. In
malaria studies conducted in sub-Saharan countries, the
main risk exposure factor includes the house location of
subjects [14,15] due to specific environments, which influ-
ence malaria transmission. The distribution of mosquito
breeding sites within villages is not uniform, thus, the ex-
posure varies within villages, and this must be taken into
account when assessing treatment effects. As shown in
Figure 1, the simulation data provided proof of an existing
confounding factor that needs to be taken into account.
In fact, the RRs and their confidence intervals esti-
mated on simulated data trended toward the null hy-
pothesis (more close for RRs confidence intervals to
include 1) compared to the RRs and their confidence in-
tervals estimated on observed data. These variations were
more important for the AG-CP and the Shared gamma
frailty models despite their power (ability to detect signifi-
cant effect) than in the PWP-CP and GEE Poisson distri-
bution models. But, according to the empirical coverage
rate as described by Burton et al. [31], the PWP-CP
remained the more robust to the addition of the simulated
confounding factor.
Conclusions
In the context of malaria, statistical models have to take
recurrent events and discontinuous time into account to
better estimate effects of covariates such as treatments or
risk factors such as age on malaria recurrent episodes. Inthis context, the three extended Cox models presented
here are of high interest and showed similar results.
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